Literature DB >> 19171341

Effect of aortic valve stenosis on haemostasis is independent from vascular atherosclerotic burden.

Pawel Petkow Dimitrow1, Marta Hlawaty, Anetta Undas, Maria Sniezek-Maciejewska, Bartosz Sobień, Ewa Stepień, Wiesława Tracz.   

Abstract

OBJECTIVE: The aim of study was to assess whether activation of blood coagulation and platelets is enhanced in aortic stenosis (AS) and if so, to determine factors that might modulate these processes. PATIENTS/
METHODS: Seventy-five patients with AS (48 males, 27 females, aged 65+/-10 years) were enrolled in the study. A control group comprised 75 age- and sex-matched subjects. We determined markers of thrombin generation (thrombin-antithrombin complex [TAT], prothrombin fragment 1+2 [F1+2]), platelet activation (soluble CD40 ligand [sCD40L], beta-thromboglobulin [beta-TG], P-selectin) in peripheral blood plasma. The extent of atherosclerosis in the carotid and coronary arteries was assessed as a potential confounding factor.
RESULTS: Mean concentrations of thrombin and platelet markers were higher approximately two-fold in the AS group than in controls (p<0.005 for all comparisons). Maximal gradient was positively associated with TAT (r=0.61, p<0.001), F1+2 (r=0.60, p<0.001), sCD40L (r=0.52, p<0.01) and beta-TG (r=0.70, p<0.001). Aortic valve area (AVA) negatively associated only with one platelet marker, beta-TG (r=-0.30, p<0.05). The presence of concomitant atherosclerotic plaque in the carotid (in 65% of patients) or coronary arteries (in 43% of patients) did not influence thrombin generation and platelet activation in patients with AS.
CONCLUSIONS: AS predisposes to prothrombotic state. Maximal gradient as an index of turbulent flow associated with activation of coagulation and platelets. In contrast, the small aortic valve area was not closely related to these parameters.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19171341     DOI: 10.1016/j.atherosclerosis.2008.12.029

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

1.  Activated factor XI and tissue factor in aortic stenosis: links with thrombin generation.

Authors:  Joanna Luszczak; Anetta Undas; Matthew Gissel; Maria Olszowska; Saulius Butenas
Journal:  Blood Coagul Fibrinolysis       Date:  2011-09       Impact factor: 1.276

2.  Platelet reactivity in patients undergoing transcatheter aortic valve implantation.

Authors:  Katia Orvin; Alon Eisen; Leor Perl; Noa Zemer-Wassercug; Pablo Codner; Abid Assali; Hana Vaknin-Assa; Eli I Lev; Ran Kornowski
Journal:  J Thromb Thrombolysis       Date:  2016-07       Impact factor: 2.300

3.  Changes in platelet indices in children with bicuspid aortic valve.

Authors:  Aylin Canbolat Ayhan; Yusuf Izzet Ayhan; Ozlem Kalaycık; Cetin Timur; Asım Yoruk
Journal:  Pediatr Cardiol       Date:  2014-11-21       Impact factor: 1.655

4.  Outcomes associated with dual antiplatelet therapy after myocardial infarction in patients with aortic stenosis.

Authors:  Andreas Martinsson; Xinjun Li; Christian Torp-Pedersen; Bengt Zöller; Pontus Andell; Charlotte Andreasen; Gunnar Gislason; Lars Køber; Kristina Sundquist; J Gustav Smith; Charlotte Andersson
Journal:  Int J Cardiol       Date:  2019-01-19       Impact factor: 4.164

5.  Monitoring of Serial Presurgical and Postsurgical Changes in the Serum Proteome in a Series of Patients with Calcific Aortic Stenosis.

Authors:  Kazumi Satoh; Kazuo Yamada; Tomoko Maniwa; Teiji Oda; Ken-ichi Matsumoto
Journal:  Dis Markers       Date:  2015-05-20       Impact factor: 3.434

6.  Proteomic analysis of human plasma in chronic rheumatic mitral stenosis reveals proteins involved in the complement and coagulation cascade.

Authors:  Somaditya Mukherjee; Mashanipalya G Jagadeeshaprasad; Tanima Banerjee; Sudip K Ghosh; Monodeep Biswas; Santanu Dutta; Mahesh J Kulkarni; Sanjib Pattari; Arun Bandyopadhyay
Journal:  Clin Proteomics       Date:  2014-09-24       Impact factor: 3.988

7.  Microparticle-Induced Coagulation Relates to Coronary Artery Atherosclerosis in Severe Aortic Valve Stenosis.

Authors:  Patrick Horn; Gülsüm Erkilet; Verena Veulemans; Patric Kröpil; Leon Schurgers; Tobias Zeus; Christian Heiss; Malte Kelm; Ralf Westenfeld
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

8.  Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease.

Authors:  Inki Moon; So-Ryoung Lee; Eue-Keun Choi; Euijae Lee; Jin-Hyung Jung; Kyung-Do Han; Myung-Jin Cha; Seil Oh; Gregory Y H Lip
Journal:  J Clin Med       Date:  2019-10-04       Impact factor: 4.241

9.  Platelet expression of stromal cell-derived factor-1 is associated with the degree of valvular aortic stenosis.

Authors:  Thomas Wurster; Roland Tegtmeyer; Oliver Borst; Dominik Rath; Tobias Geisler; Meinrad Gawaz; Boris Bigalke
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

10.  Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban.

Authors:  Günter Breithardt; Helmut Baumgartner; Scott D Berkowitz; Anne S Hellkamp; Jonathan P Piccini; Yuliya Lokhnygina; Jonathan L Halperin; Daniel E Singer; Graeme J Hankey; Werner Hacke; Richard C Becker; Christopher C Nessel; Kenneth W Mahaffey; Robert M Califf; Keith A A Fox; Manesh R Patel
Journal:  Heart       Date:  2016-02-17       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.